ILANIT 2020

Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice

Dorit Omer 1,2 Orit Harari-Steinberg 1,2 Yehudit Gnatek 1,2 Oren Pleniceanu 1,2 Sanja Goldberg 1,2 Osnat Cohen-Zontag 1,2 Sara Pri-Chen 3 Itamar Kanter 4 Nissim Ben Haim 4 Eli Becker 4 Yaron Fuchs 5 Tomer Kalisky 4 Zohar Dotan 6,7 Benjamin Dekel 1,2,7,8
1Pediatric Stem Cell Research Institute, Edmond and Lily Sara Children’s Hospital, Sheba Medical Center, Tel Hashomer, Israel
2Pediatric Research Center for Genetics, Development and Environment, Sackler School of Medicine, Tel Aviv University, Israel
3The Maurice and Gabriela Goldschleger Eye Research Institute, Sheba Medical Center, Israel
4Faculty of Engineering and Bar-Ilan Institute of Nanotechnology and Advanced Materials (BINA), Bar-Ilan University, Israel
5Laboratory of Stem Cell Biology & Regenerative Medicine, Department of Biology, Technion – Israel Institute of Technology, Israel
6Department of Urology, Sheba Medical Center, Tel Hashomer, Israel
7Sackler School of Medicine, Tel Aviv University, Israel
8Division of Pediatric Nephrology, Safra Children’s Hospital, Sheba Medical Center, Israel

End-stage renal disease is a worldwide epidemic requiring renal replacement therapy. Harvesting tissue from failing kidneys and autotransplantation of expanded committed progenitors giving rise to renal parenchyma could theoretically allow for the restoration of kidney function delaying or preventing the need for dialysis or a renal allograft. Here we utilized healthy and end-stage human adult kidneys to robustly expand proliferative kidney epithelial cells and establish 3D-kidney epithelial cultures termed nephrospheres (nSPH). Formation of nephrospheres recapitulates renal developmental programs to reestablish renal identity and revitalize renal epithelia in primary cultures. Transplantation into NOD/SCID mice show that 3D-nSPH restore self-organogenetic properties lost in adherent cultures, allowing in turn efficient engraftment and long-term survival as tubular structures and demonstrating self-organization as critical to prolonged in vivo cell survival. Moreover, long-term tubular engraftment of human nSPH proved to be functionally beneficial in murine models of chronic kidney disease. Remarkably, in vitro, nSPH inhibited pro-fibrotic collagen production in cultured fibroblasts via paracrine modulation of STAT6/IL13 while in vivo, transplanted nSPH induced transcriptional signatures of proliferation and a release from the quiescent state in host tubules potentially re-activating endogenous regeneration. These data support the use of human nSPH for autologous renal cell therapy.









Powered by Eventact EMS